Clinical Trials
Your Expert Guide to Developing Psychoactive Substances
Practical Approaches to Conducting
Early Clinical Trials with Psychedelics
Watch this on-demand webinar on the development of psychedelics. Altasciences’ experts, Dr. Setnik and Dr. Milovan, provide an overview of the pragmatic and cost-effective approaches to conducting early-phase clinical trials with psychedelics, including adequate setup of the clinical pharmacology unit.
Speak with our experts to discuss your drug development needs.
You may also be interested in the following:
Webpages:
Scientific Journal: Challenges Associated with Schedule I Therapeutic Development
Altasciences transforms the traditional outsourcing paradigm by simplifying and streamlining drug development solutions, whether for a single study or multiple programs, to offer an integrated/synchronized approach to CRO and CDMO services from lead candidate selection to clinical proof of concept, and beyond.
Five Reasons to Choose Canada for Your Clinical Trials—From the Webinar Demystifying the Conduct of Clinical Trials in Canada
Canadian research facilities are becoming a popular choice for American and European sponsors, carrying out hundreds of clinical trials each year.
Get Quicker Clinical Trial Data
Accelerate Your Clinical Trials with Liquid-Filled Capsules
Liquid-filled, two-piece capsules offer countless advantages over other solid dosage forms―ease of scalability and manufacturing, faster absorption, simpler packaging, and higher product stability, to name a few.
They are also the recommended dosage form for insoluble or highly potent APIs, and are known to accelerate product development because they can be made with fewer excipients than other solid dosage forms, such as tablets.
Discover the full benefits of using liquid-filled capsules in your clinical trials, or view this infographic for a quick tutorial.
Related Resources:
- Webpage: Contract Manufacturing and Analytical Solutions
- eBook: Applications of Liquid-Filled Capsules in Drug Development
- Webinar: Manufacturing Solutions Using Liquid-Filled Capsules
Altasciences transforms the traditional outsourcing paradigm by simplifying and streamlining drug development solutions, whether for a single study or multiple programs, to offer an integrated/synchronized approach to CRO and CDMO services from lead candidate selection to clinical proof of concept, and beyond.
Accelerate Your Data with Our Co-located Clinic and Lab
Ensuring Chain of Custody from Clinic to Lab
Did you know that our Canadian clinical facility is only a 15-minute drive from our bioanalytical facility?
This two-minute video provides an overview of our workflows, optimized to ensure timely collection, processing, transport, and rapid analysis of your samples for expedited go/no-go decision-making. Altasciences’ highly trained clinical staff and lab analysts understand the time-sensitive nature of your projects. Real-time access to essential data is our top priority.
Speak with one of our experts to learn more about our solution and how we can support your program.
Altasciences transforms the traditional outsourcing paradigm by simplifying and streamlining drug development solutions, whether for a single study or multiple programs, to offer an integrated/synchronized approach to CRO and CDMO services.
Have five minutes? Take a look at these:
Scratching the Surface of Dermal Testing
Best Practices for a Successful, Multi-Step Data Journey
In this latest issue of The Altascientist, we guide you through the complex, multi-step data journey for Phase I clinical trials, from study conceptualization and protocol development, to data collection and analysis, through to final regulatory submission. We highlight best practices and approaches to mitigate challenges, and show how integration and collaboration build the strongest datasets for your drug development program.
Speak with an expert to learn more about our service offering.
Have a few more minutes? Check out these insightful resources:
- The Altascientist—CDISC Data Standards
- Fact Sheet—Comprehensive Research Support
- Blog—Data Management Excellence
New Generation Pain Relief Without Opioids
Opioids are highly effective at relieving both acute and chronic pain. However, this benefit comes at a significant cost: they are also highly addictive.
Clinical Research Solution for Ophthalmic Products
Altasciences has extensive experience conducting early phase clinical trials for ophthalmic products targeting numerous eye diseases and disorders, such as open angle glaucoma, ocular hypertension, and dry eye.
Our clinical solution includes:
- In-house ophthalmologist with over 20 years of experience
- Three North American inpatient units from coast to coast with over 500 beds — fully equipped inpatient and outpatient capabilities
- Robust network of ophthalmology sites in close proximity to our clinics to conduct studies on both the front and back of the eyes
- Database of over 400K participants for healthy normal and patient recruitment
Book a consult with one of our experts to learn more about our solution and how we can support your program.
You may also be interested in the following:
- Fact Sheet: Ophthalmology Clinical Research Services
- Webpage: Comprehensive Solutions for Ophthalmic Drug Development
- The Altascientist—A scientific journal: The Complexities of Early Phase Ophthalmic Drug Development
Altasciences transforms the traditional outsourcing paradigm by simplifying and streamlining drug development solutions, whether for a single study or multiple programs, to offer an integrated/synchronized approach to CRO and CDMO services from lead candidate selection to clinical proof of concept, and beyond.
Ophthalmic End-to-End Drug Development Solutions